About E-Synergy
E-Synergy is a venture capital firm founded in 1999. It is primarily based out of London, United Kingdom. As of Dec 2012, E-Synergy has invested in 36 companies. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Environment Tech and Life Sciences. Most recently it participated in the $***** Seed round of Sian's Plan Overall, E-Synergy portfolio has seen 3 IPOs and 9 acquisitions including key companies like Blackstar Amplification, Armata Pharmaceuticals and AuditComply. A lot of funds co-invest with E-Synergy, with names like EMBA sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Unattributed & 3 more
Portfolio IPOs
Portfolio Acquisitions
E-Synergy's List of Top Investments
E-Synergy has a portfolio of 36 companies. Their most notable investmentis in PathXLTheir portfolio spans across United Kingdom, Ireland, Scotland and 1 more locations. They have invested in Enterprise Applications, Environment Tech, Life Sciences and 16 other sectors, across stages such as Series A, Unattributed and 3 more. Here is the list of top investments by E-Synergy:
1. Nuada
Provider of carbon capture technology solutions. It uses energy-efficient filtration machines that make carbon capture commercially viable and pave the path for zero carbon emissions in industry. It utilizes solid sorbent materials and operates via vacuum swing adsorption gas separation technology.
Key facts about Nuada
- Founded Year: 2012
- Location: Newtownabbey (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $12.8M
- Employee Count: 67 as on Aug 31, 2026
- Investors: NetScientific, EIC Fund and 22 Others
- Latest Funding Round: Grant (prize money), Apr 08, 2025, $*****
- Highlight: Editors' Pick
Manufacturer of guitar amplifiers and related accessories. They design and produce amplifiers for electric, acoustic, and bass guitars, along with audio interfaces, cabinets, pedals, and plugins. The company focuses on innovative designs and patented technologies to provide musicians with high-quality amplification solutions for various applications, from home practice to professional studio and live performance settings. Their product line includes several series catering to different needs and preferences.
Key facts about Blackstar Amplification
- Founded Year: 2007
- Location: Northampton (United Kingdom)
- Annual Revenue: £10M - £50M as on Apr 30, 2022
- Stage: Acquired
- Total Funding till date: $5.49M
- Employee Count: 63 as on Aug 31, 2026
- Investors: E-Synergy, Catapult Ventures and 1 Other
- Latest Funding Round: Series A, Aug 01, 2012, $*****
- Highlight: Acquired
Manufacturer of metal-organic frameworks for industrial applications like carbon capture. The company’s technology enables the production of these materials at an industrial scale. Metal-organic frameworks are used in biogas upgrading, water harvesting, and gas storage. The company offers services to determine the technical feasibility and economic viability of metal-organic frameworks.
Key facts about Promethean Particles
- Founded Year: 2007
- Location: Nottingham (United Kingdom)
- Annual Revenue: £0 - £1M as on Nov 30, 2017
- Stage: Series A
- Total Funding till date: $13.5M
- Employee Count: 32 as on Aug 31, 2026
- Investors: EIC Fund, Foresight Group and 39 Others
- Latest Funding Round: Series A, Aug 14, 2024, $*****
- Highlight: Editors' Pick
_1559280053588.png?format=webp&height=120&width=120){kind=logo}
Developer of phage therapeutics. It target key antibiotic-resistant bacteria. The lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of proprietary synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa.
Key facts about Armata Pharmaceuticals
- Founded Year: 1989
- Location: Los Angeles (United States)
- Stage: Public
- Employee Count: 75 as on Aug 31, 2026
- Investors: BioScience Managers, Cystic Fibrosis Foundation and 6 Others
- Latest Funding Round: Post IPO, Apr 01, 2022, $*****
- Highlight: Public
5. AuditComply
Audit Comply provides mobile audit management solutions for enterprises to manage operational risk, ensure workplace safety and meet compliance requirements. The product AuditPlus offers risk management, template assessment, automated risk reporting, CAPA management, alerts & notifications, set thresholds, dashboarding, and audit questionnaires. It serves food, logistics, finance, manufacturing, and property management. Some of the customers are Westland, Lousiana Foods, Dunbia, Lakeland Diaries, etc.
Key facts about AuditComply
- Founded Year: 2014
- Location: Belfast (United Kingdom)
- Stage: Acquired
- Total Funding till date: $189K
- Employee Count: 16 as on May 31, 2026
- Investors: Co-Fund NI, Invest Northern Ireland and 16 Others
- Latest Funding Round: Series A, Dec 05, 2017, $*****
- Highlight: Acquired
E-Synergy's Investments by Stage
E-Synergy has made 5 investments in Series A stage with an average round size of $2.18M, 3 investments in Unattributed stage with an average round size of $822K, 2 investments in Seed stage with an average round size of $602K, 1 investment in Grant (prize money) stage with an average round size of $103K and 1 investment in Series B stage with an average round size of $1.61M.Stage of entry | No. of Investments |
|---|---|
Series A | 5 |
Unattributed | 3 |
Seed | 2 |
Grant (prize money) | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
E-Synergy's Investments by Sector
E-Synergy has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Healthcare, Sustainability Tech and Vertical SaaS. Notably, it has invested in 29 Enterprise (B2B) companies, 27 Tech companies, 16 Software companies and at least 10 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
Enterprise Applications | 3 |
Healthcare | 2 |
Sustainability Tech | 2 |
Vertical SaaS | 2 |
Others | 7 |
Note: We have considered here, only first round of investments
E-Synergy's Investments by Geography
E-Synergy has made most investments in United Kingdom (11), followed by Scotland where it has made 2 investments.Country | No. of Investments |
|---|---|
United Kingdom | 11 |
Scotland | 2 |
Ireland | 1 |
Note: We have considered here, only first round of investments
E-Synergy's recent investments
E-Synergy has not made any investment in 2026 so far.Here are the most recent investments by E-Synergy:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 20, 2012 | Ireland | Seed | 3649 | - | |
Nov 13, 2012 | United Kingdom | Series B | 4219 | [+3] | |
May 14, 2012 | United Kingdom | Seed | 8324 | - | |
Jan 20, 2012 | United Kingdom | Series A | 8168 | - | |
Jan 27, 2011 | United Kingdom | Series A | 3480 | - |
IPOs and Publicly Listed companies in E-Synergy's Portfolio
3 of E-Synergy's portfolio companies have become public. Armata Pharmaceuticals got listed on the Frankfurt Stock Exchange (FRA), in Mar 2000.Here are E-Synergy's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 10, 2000 | - | - | 3566 | |
- | Jul 06, 2007 | Unattributed | 7101 | |
- | - | - | 7199 |
_1559280053588.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Acquired companies in E-Synergy's Portfolio
9 companies from E-Synergy's portfolio have been acquired. The most recent acquisition was AuditComply in Oct 2025 by Nulogy for $*****.Here are E-Synergy's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 14, 2025 | - | - | 7642 | |
Jul 21, 2021 | - | - | 1331 | |
Apr 02, 2019 | - | - | 5488 | |
Mar 29, 2018 | - | - | 8518 | |
Jul 14, 2017 | - | - | 1834 |
Co-investors of E-Synergy
Over the past 21 years, 28 investors have co-invested in E-Synergy's portfolio companies. This includes funds and angels.
- Invested before E-Synergy: Catapult Ventures, Crescent Capital and 2 others have invested in rounds before E-Synergy. There are 2 companies where Catapult Ventures has invested before E-Synergy and 1 company where Crescent Capital has invested before E-Synergy.
- Top Co-investors of E-Synergy: 5 investors entered a company along with E-Synergy. These include investors like EMBA (1 company).
- Invested after E-Synergy: A total of 19 investors have invested in E-Synergy's portfolio after their investments. Top Investors include Europa (3 companies), EIC Fund (1 company) and Midlands Engine Investment Fund (1 company).
Recent News related to E-Synergy
•
Lovestruck raises £285,000 for continued expansion of dating in London and beyond PRWeb•Jan 10, 2010•Lovestruck, E-Synergy
•
Every UK VC deal in 2007 – TechCrunchTechCrunch+•Apr 28, 2008•Picsel, DCM Ventures, Capital Group, SMBC Venture Capital and 10 others
•
